Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionEverSource Wealth Advisors, LLC
Latest Disclosed Ownership5,392 shares
Latest Disclosed Value $ 19,303
EverSource Wealth Advisors, LLC reports 91.82% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 15, 2026 - EverSource Wealth Advisors, LLC filed a 13F-HR/A form disclosing ownership of 5,392 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $15,178 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 2,811 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 91.82% during the quarter. The current value of the position is $13,156 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F/A-1 ROCKET PHARMACEUTICALS INC COM Stock 77313F106 5,392 2,581 91.82 19 111.11 0.0001
2026-05-14 2026-03-31 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 1,265 -1,546 20 0.0001
2026-02-06 2025-12-31 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 2,811 297 11.81 10 12.50 0.0004
2025-11-10 2025-09-30 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 2,514 915 57.22 8 166.67 0.0003
2025-08-13 2025-06-30 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 1,599 1,376 617.04 4 200.00 0.0002
2025-05-13 2025-03-31 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 223 136 156.32 1 0.00 0.0001
2025-02-10 2024-12-31 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 87 7 8.75 1 -50.00 0.0001
2024-05-13 2024-03-31 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 80 0 0.00 2 0.00 0.0002
2024-02-09 2023-12-31 13F ROCKET PHARMACEUTICALS INC COM Stock 77313F106 80 80 2 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.